TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive Also in this 8-page issue: John Montgomery, a founder of BioCryst Pharmaceuticals and a former member of the President’s Cancer Panel, dead. July 2, 2004
TCL Archive In Brief: Selection Of NCI Director Extended By Month; Fisher Named NSABP Scientific Director March 17, 1995
